Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC Update - January 2019

The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines.

Tiotropium (Spiriva Respimat®) has been accepted for use as add-on maintenance bronchodilator treatment in patients aged 6 years and older with severe asthma who experienced one or more severe asthma exacerbations in the preceding year.

Ertugliflozin (Steglatro®) has been accepted for restricted use in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:

  • As monotherapy in patients for whom the use of metformin is considered inappropriate due to intolerance or contraindication.
  • In addition to other medicinal products for the treatment of diabetes

The restriction limits use as monotherapy to patients who would otherwise receive a dipeptidyl peptidase-4 inhibitor and in whom a sulphonylurea or pioglitazone is not appropriate.

Semaglutide (Ozempic®) has been accepted for restricted use in the treatment of adults with insufficiently controlled type 2 diabetes mellitus (T2DM) as an adjunct to diet and exercise when used in addition to other medicinal products for the treatment of diabetes. The restriction limits this drug to add on use only as the submission from the manufacturer did not relate to use as monotherapy when metformin is considered inappropriate.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC Update - January 2019' on Email Share 'SMC Update - January 2019' on Delicious Share 'SMC Update - January 2019' on Digg Share 'SMC Update - January 2019' on Facebook Share 'SMC Update - January 2019' on reddit Share 'SMC Update - January 2019' on StumbleUpon Share 'SMC Update - January 2019' on Twitter

atomic-wealth

No Comments to “SMC Update - January 2019”

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.

atomic-wealth
fond-illness
summer